The FTSE 100 closed lower on Thursday with hopes for peace between the US and Iran hanging in the balance as new reports of deal progress followed renewed hostilities between the two countries. "The ...

Hamak Strategy Ltd, up 31% at 0.95 pence, 12-month range 0.40p-7.50p. The Africa-focused gold explorer reports "exceptional gold grades" from testing at the Akoko gold project in southwest Ghana.

Vesuvius PLC on Thursday said cost savings, acquisition synergies, price rises and the improving momentum expected across key markets should support an improved second half of 2026. The London-based ...

DP Poland PLC on Thursday reported increased pretax losses in 2025 despite strengthened trading towards the end of the year. The operator of Domino's pizza chain restaurants in Poland and Croatia said ...

Ultimate Products PLC on Thursday said it expects full-year revenue to be slightly ahead of market consensus despite continued subdued consumer demand. The Oldham, England-based branded homeware ...

SSE PLC on Thursday boosted its dividend as it reported earnings towards the higher end of guidance, and said GBP33 billion investment plans out to 2030 are "well under way". The Perth, Scotland-based ...

Gresham House Energy Storage Fund PLC on Thursday said it has signed sale and purchase agreements for two pipeline projects totalling 297 megawatts or 540 megawatt hours. The investor in utility-scale ...

Blackrock Frontiers Investment Trust PLC on Thursday said it underperformed its benchmark during the interim period, but noted the combination of favourable structural trends, ongoing economic reform ...

The ousted chair of BP PLC has rejected "lies" about his conduct and said his views on cost-cutting and calling out "excessive expenditure" on things like a limousine or private flight were not shared ...

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday. FTSE 100 winners Babcock International Group PLC, up 1.9% at 1,084.50 pence, ...

SSE raises its dividend and reports results towards the upper end of guidance and Johnson Matthey agrees to buy catalyst firm Cormetech for USD360 million. SSE says its full-year financial results are ...

GSK PLC on Thursday reported "positive" phase 3 trial data for its hepatitis B treatment, Bepirovirsen, which it said could "redefine" treatment for the disease. The London-based pharmaceuticals firm ...